News & Updates
Filter by Specialty:
Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
Patients with heart failure (HF) with preserved ejection fraction (HFpEF), obesity, and type 2 diabetes (T2D) show a favourable response to tirzepatide despite less pronounced weight loss, reports a study.
Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
17 Sep 2025
Inactive disease a viable target in tofacitinib-treated patients with JIA
Treatment with tofacitinib improves the rates of Juvenile Arthritis Disease Activity Score (JADAS) in 10 joints (JADAS10)-clinically inactive disease (CID) and American College of Rheumatology (ACR)-CID in patients with juvenile idiopathic arthritis (JIA), with improvements sustained over time, a study has shown. Additionally, a few patients have achieved JADAS10 remission.
Inactive disease a viable target in tofacitinib-treated patients with JIA
16 Sep 2025
Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis
In patients with suspected sarcoidosis, small airway biopsy (SAB) guided by ultrathin bronchoscopy (UTB) shows promise for increasing the detection rate of granulomatous inflammation while minimizing the risk of pneumothorax associated with transbronchial lung biopsy (TBLB).